Back to results
US 2024/0424075 A1Published application
Immunoreactive peptides
AssigneeResearch Development Foundation
InventorsJere McBRIDE, David WALKER
Life of this patent
Estimating the term…
Abstract
Immunoreactive engineered polypeptides are provided. The engineered polypeptides can be used to diagnose or induce an immune response against E. chaffeensis or E. canis.
Claims35
An immunoreactive polypeptide comprising SEQ ID NO:1 or SEQ ID NO:7, or a polypeptide at least 90% identical thereto.
3-5. (canceled)
(canceled)
21-33. (canceled)
35-36. (canceled)
40-41. (canceled)
48-67. (canceled)
Dependencies are inferred from the claim text.